Scilex Holding Company Patent Applications Pending
3 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2025-06-11: Application 19234704; Invention METHODS OF TREATING PAIN; Applicant Scilex Holding Company; Status Docketed New Case - Ready for Examination.
- 2023-04-05: Application 18296247; Invention ORAL DELAYED BURST FORMULATION OF LOW-DOSE NALTREXONE AND METHODS FOR TREATING FIBROMYALGIA AND LONG COVID; Applicant Scilex Holding Company; Status Non Final Action Mailed.
- 2021-10-05: Application PCTUS2021053645; Invention ORAL DELAYED BURST FORMULATION OF LOW-DOSE NALTREXONE OR NALOXONE AND METHODS FOR TREATING FIBROMYALGIA AND LONG COVID; Applicant SCILEX HOLDING COMPANY; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2025-06-11 | 19234704 | METHODS OF TREATING PAIN | Scilex Holding Company | Docketed New Case - Ready for Examination | US20260124175A1 | Sagar Munjal Anirudh Gautam | United States United States | CENTRAL, DOCKET |
| 2023-04-05 | 18296247 | ORAL DELAYED BURST FORMULATION OF LOW-DOSE NALTREXONE AND METHODS FOR TREATING FIBROMYALGIA AND LONG COVID | Scilex Holding Company | Non Final Action Mailed | US20230372328A1 | Shanmuka Harish CHALAMURI Ashok PERUMAL Yu-Hsing TU Tien-Li LEE Zhenhuan ZHENG | United States United States United States United States United States | TCHERKASSKAYA, OLGA V |
| 2021-10-05 | PCTUS2021053645 | ORAL DELAYED BURST FORMULATION OF LOW-DOSE NALTREXONE OR NALOXONE AND METHODS FOR TREATING FIBROMYALGIA AND LONG COVID | SCILEX HOLDING COMPANY | RO PROCESSING COMPLETED-PLACED IN STORAGE | SHANMUKA HARISH CHALAMURI ASHOK PERUMAL ZHENHUAN ZHENG TIEN-LI LEE YU-HSING TU | United States United States United States United States United States |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |